CEBPB and glioblastoma: A strong case has been made for glioblastoma, where high C/EBPβ expression levels correlate with a poor prognosis for the patient and C/EBPβ together with STAT3 plays a key role in establishing a mesenchymal gene expression signature that is responsible for the aggressiveness of high-grade glioblastomas [46–48].